Peninsula Wealth’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Peninsula Wealth's GILD Position: Q4 2024 in Review
Peninsula Wealth reduced its Gilead Sciences (GILD) stake by 2.1% in Q4 2024, selling an estimated $80.5K and leaving 41,786 shares worth $3.86M. The position accounts for 0.66% of the portfolio, ranked #23.
Peninsula Wealth first reported a position in GILD in Q1 2018 and has held it in 28 quarters since. The position peaked at $5.76M in Q3 2018. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.
- Peninsula Wealth held 41,786 shares of Gilead Sciences worth $3.86M as of Q4 2024.
- Peninsula Wealth sold 894 Gilead Sciences shares in Q4 2024, an estimated $80.5K.
- Gilead Sciences made up 0.66% of Peninsula Wealth's portfolio in Q4 2024, its #23 holding.
- Peninsula Wealth first reported a position in Gilead Sciences in Q1 2018 and has held it in 28 quarters since.
- Peninsula Wealth's Gilead Sciences position peaked at $5.76M in Q3 2018.
- 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.
Based on Peninsula Wealth's 13F filing for Q4 2024, filed 13 Feb 2025.